TrialReader


Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers

NCT00948129 — Not applicable, Completed, 626 participants, M.D. Anderson Cancer Center

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Project ACTION: Adult Smoking Cessation Treatment Through Innovative Outreach to Neighborhoods

RegistryNCT00948129
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, prevention
Enrollment626 (Actual)
SponsorM.D. Anderson Cancer Center (Other); collaborators: National Cancer Institute (NCI)
ConditionsCigarette Smoker, Current Every Day Smoker
InterventionsLaboratory Biomarker Analysis, Smoking Cessation Intervention, Telephone-Based Intervention, Tobacco Cessation Counseling (Other, behavioral)
Datesstart 2009-08-10, primary completion 2021-02-10, completion 2021-02-10, first posted 2009-07-29, last updated 2023-01-20
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Cigarette Smoker All trials for Current Every Day Smoker All trials of Laboratory Biomarker Analysis All trials of Smoking Cessation Intervention

-Summary

This trial studies how well a mobile smoking cessation intervention works in enhancing cancer outreach in low-income adult smokers. Mobile smoking cessation intervention may help smokers quit or cut back on smoking, and help increase the range of cancer prevention services provided to low-income adult smokers.

Expand all sections  ·  Collapse all

+Detailed description

PRIMARY OBJECTIVES:

I. Compare the efficacy of three smoking cessation interventions targeting community based low-income uninsured and underinsured individuals in a group-randomized trial.

II. Evaluate the role of quit motivation, nicotine withdrawal, risk perception, self-efficacy, social support, and negative affect as potential mediators of smoking abstinence.

III. Compare the cost-effectiveness of the three treatment conditions.

OUTLINE: Participants are randomized to 1 of 3 groups.

GROUP I (STANDARD CARE): Participants undergo standard of care smoking cessation intervention consisting of brief advice to quit smoking, nicotine replacement therapy (NRT), and self-help written materials.

GROUP II (ENHANCED CARE): Participants undergo standard of care smoking cessation intervention as in Group I and attend a health feedback counseling session at baseline. Participants also receive access to a smoking cessation hotline telephone number and supportive text messages daily for 12 weeks.

GROUP III (INTENSIVE CARE): Participants undergo standard of care smoking cessation intervention as in Group I and attend a health feedback counseling session at baseline. Participants also receive access to a smoking cessation hotline telephone number, supportive text messages daily for 12 weeks, and a smoking cessation telephone call over 15 minutes weekly for 12 weeks.

After completion of study, participants are followed up at 3, 6, and 12 months.

+Arms and interventions

ArmTypeInterventionsDescription
Group I (standard care)Active comparatorOther: Laboratory Biomarker Analysis; Behavioral: Smoking Cessation InterventionParticipants undergo standard of care smoking cessation intervention consisting of brief advice to quit smoking, NRT, and self-help written materials.
Group II (enhanced care)ExperimentalOther: Laboratory Biomarker Analysis; Behavioral: Smoking Cessation Intervention; Other: Tobacco Cessation CounselingParticipants undergo standard of care smoking cessation intervention as in Group I and attend a health feedback counseling session at baseline. Participants also receive access to a smoking cessation hotline telephone number and supportive text messages daily for 12 weeks.
Group III (intensive care)ExperimentalOther: Laboratory Biomarker Analysis; Behavioral: Smoking Cessation Intervention; Behavioral: Telephone-Based Intervention; Other: Tobacco Cessation CounselingParticipants undergo standard of care smoking cessation intervention as in Group I and attend a health feedback counseling session at baseline. Participants also receive access to a smoking cessation hotline telephone number, supportive text messages daily for 12 weeks, and a smoking cessation telephone call over 15 minutes weekly for 12 weeks.
  • Laboratory Biomarker Analysis (Other): Correlative studies
  • Smoking Cessation Intervention (Behavioral), also known as Smoking and Tobacco Use Cessation Interventions: Undergo standard of care smoking cessation intervention
  • Telephone-Based Intervention (Behavioral): Undergo telephone based smoking cessation intervention
  • Tobacco Cessation Counseling (Other): Undergo smoking cessation counseling

+Outcome measures

Primary outcomes

  • Smoking abstinence rate [At 12 months]: The primary method of analysis will be mixed-model logistic regression.
  • Cost-effectiveness [At 12 months]: Will perform an incremental cost-effectiveness analysis by comparing the expected economic costs and clinical benefits of the three strategies. Will create a decision-analytic model using TreeAge Pro 2007 software to conduct the incremental cost-effectiveness analysis.

Secondary outcomes

  • Salivary cotinine levels [At 12 months]: Salivary cotinine will be measured using the NicAlert test system.

+Eligibility

Sex: All, ages: 18 Years to any, accepts healthy volunteers

Inclusion Criteria:

* Smoked at least 100 cigarettes in lifetime
* English or Spanish speaking
* Currently smoking at least 5 cigarettes a day, on average
* Willing to set a quit smoking date within a week of the enrollment

Exclusion Criteria:

* Positive history of a medical condition that precludes use of the nicotine patch
* Current use of nicotine replacement therapy (NRT)
* Current use of other smoking cessation medications (e.g., Chantix or Zyban)
* Pregnant or nursing
* Enrolled in another smoking cessation study

+Locations (1)

FacilityCityCountryStatus
M D Anderson Cancer CenterHouston, TexasUnited States

+Publications

  • Results publication: Vidrine DJ, Frank-Pearce SG, Vidrine JI, Tahay PD, Marani SK, Chen S, Yuan Y, Cantor SB, Prokhorov AV. Efficacy of Mobile Phone-Delivered Smoking Cessation Interventions for Socioeconomically Disadvantaged Individuals: A Randomized Clinical Trial. JAMA Intern Med. 2019 Feb 1;179(2):167-174. doi: 10.1001/jamainternmed.2018.5713. PMID 30556832
  • Results publication: Daly AT, Deshmukh AA, Vidrine DJ, Prokhorov AV, Frank SG, Tahay PD, Houchen ME, Cantor SB. Cost-effectiveness analysis of smoking cessation interventions using cell phones in a low-income population. Tob Control. 2019 Jan;28(1):88-94. doi: 10.1136/tobaccocontrol-2017-054229. Epub 2018 Jun 9. PMID 29886411
  • Results publication: Vidrine DJ, Fletcher FE, Danysh HE, Marani S, Vidrine JI, Cantor SB, Prokhorov AV. A randomized controlled trial to assess the efficacy of an interactive mobile messaging intervention for underserved smokers: Project ACTION. BMC Public Health. 2012 Aug 25;12:696. doi: 10.1186/1471-2458-12-696. PMID 22920991

+Study documents

+Investigators

+Funding

NIH grants: R01CA141628

My Notes